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ABSTRACT 
 
Objective:  Lactic Acid Bacteria (LAB) are used in food industry as probiotic agents. The aim 
of this study is to assess the potential health effects of airborne exposure to a mix of preblend 
(LAB and carbohydrate) and milk powder in workers. Methods: A medical questionnaire, lung 
function tests and immunological tests were carried out on 50 workers. Occupational exposure 
to inhalable dust and airborne LAB was measured. Results: Workers not using respiratory 
masks reported more symptoms of irritation than workers using protection. Workers from areas 
with higher levels of airborne LAB reported the most health symptoms and the immune 
responses of workers to LAB was higher than  compared to the immune responses of a control 
population. Conclusions: Measures to reduce exposure to airborne LAB and milk powder in 
food industries are recommended.  
 
INTRODUCTION 
 
Over the last 10-15 years, the addition of Lactic Acid Bacteria (LAB) strains to food, in 
particular in dairy food, is increasing since they are generally recognized to be beneficial to 
health 1, therefore, different species are used as food additives in order to have a positive effect 
on health. 
For the U.S. Food and Drug Administration, Bifidobacterium spp. are clearly classified 
as Generally Recognized As Safe (GRAS), although this is not the case for all Lactobacilli. It 
should be kept in mind, however, that GRAS status is only for specified food use. The 
microbes themselves are not considered GRAS, but their traditional use in dairy foods is. 
Several Lactobacillus species (e.g., L. paracasei) are not specifically on this GRAS list. 
However, the accepted character of this list is that it is partial and a microbe’s absence from the 
list does not imply that it is not safe for use2. These species are accepted as safe in Japan and 
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Europe2. Their occurrence as normal commensals of mammalian intestinal flora and their 
established safe use in a diversity of foods and food supplement products worldwide supports 
this conclusion. Thus, there is increasing general evidence that LAB have beneficial health 
effects when ingested and they are therefore more and more used in food industry. However, 
the health effects of airborne and dermal exposure to LAB strains by occupational contact in 
food processing plants had never been investigated. 
It is well known that exposure to high levels of airborne bacteria in an occupational 
environment can be associated with a wide range of health effects, in particular respiratory 
impairment, allergy and organic dust toxic syndrome3-7 . Moreover, exposure to high 
concentrations of specific bacteria could generate a specific immune response in the host. 
These immune responses are indicators of exposure and could also be indicators of an allergic 
reaction. 
The aim of this study was to assess the frequency of general, respiratory, and self-
reported health symptoms of workers exposed to dry LAB simultaneously to other powder 
(carbohydrate and milk powder). Moreover, workers’ immune responses to different LAB 
strains were investigated and an assessment of airborne LAB exposure was made. 
 
MATERIALS AND METHODS 
 
Study site 
The workers examined in this survey worked in a food processing plant. They handled 
LAB and mixed them with carbohydrate to make a so called preblend which is then mixed with 
milk powder. Evaluation took place at three different work areas on the site: i) laboratory 
(research area); ii) pilot plant (research and development area); and iii) factory (production 
site). Production of LAB in this dairy food industry started in 2002 and included strains of 
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Lactobacillus johnsonii, L. paracasei, L. rhamnosus, Bifidobacterium sp and Streptococcus sp. 
From 2003 onwards production was increased, and Personal Protective Equipment (PPE) was 
introduced for individuals exposed to airborne preblend. 
 
Study population 
All workers were currently exposed to preblends in one of the three different work areas 
described above. Fifty workers (43 men and 7 women) aged 22-60 years old participated in the 
study. No former employees were included in the study. 
All but two of the individuals were full time workers. For analysis these two part time workers 
were not separated from the group of full time workers. All participants in the survey were 
matched to one of the three work areas (laboratory, pilot plant or factory) where exposure was 
measured: six individuals worked in the laboratory, 15 in the pilot plant and 29 in the preblend 
conditioning room.  
No unexposed reference population was examined for health symptoms, however, the 
immunological analyses were obtained for an external unexposed group (n=32). All 
participants signed written informed consent before study started. In addition, all methods were 
approved by the Institute for work and Health Institutional Review Board. 
 
Questionnaire 
 A questionnaire about general health symptoms, occupational exposure, and lifestyle 
factors was designed on the basis of a questionnaire, “Evaluating Organic Dust Exposure” 8, 
and was modified for the specific requirements of this survey. It included items about dust 
exposure before the present job, the number of years’ exposure to preblend, the average 
percentage of working time (WT) exposed to preblend on during the last 12 months, and the 
average use of PPE (percentage of time wearing masks during critical periods of exposure) 
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during the last 12 months. All recorded symptoms were defined by their frequency, i.e: rare 
(less than once a month); sometimes (more than once a month) and consistently (nearly daily). 
In addition all participants were asked about their previous dust exposure before starting work 
in this industry, the weekly duration of exposure and their use of PPE. Forty-five workers were 
able to estimate the percentage of work time during which they were exposed to preblend and 
to give adequate information about the length of time during which they used PPE. Participants 
were classed into three different groups: a low exposure group (14 workers exposed to LAB for 
10% of their working time or less); an intermediate exposure group (5 workers exposed for 
more than 10% of their working time, yet who wore a mask for more than 90% of that exposure 
time); and a high exposure group (26 workers exposed for more than 10% of their working 
time, yet who wore a mask for less than or equal to 90% of the exposure time). 
 
 
Medical examination, spirometry and blood sample collection 
 All participants were examined by the same occupational health physician, who 
collected data on weight, size, blood pressure, an auscultation of the heart and lungs, and a skin 
inspection. All participants performed a spirometry test using a MicroLab Spirometer (portable 
spirometer MicroLab CatNo ML3500 by Micro Medical Ltd, Kent, UK). The best out of three 
acceptable forced expirations was taken for forced expiratory volume in one second (FEV1) 
and for forced vital capacity (FVC). These were used as the outcomes of the lung function test. 
The spirometric parameters were expressed as a percentage of the predicted values according to 
height, age and gender of a Caucasian population9.  
Following their written consent, blood samples were collected from 44 of the 50 workers. They 
were collected on the last day of the survey, transported to the laboratory on the same day at 
+4°C, and stored in frozen conditions (-80°C) in several aliquots. To examine the 
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immunological status of each worker, the blood sample was tested for antibodies against the 
different LAB used in the production site, and to carbohydrate. 
 
Airborne cultivable LAB and inhalable dust exposure assessment 
 Occupational exposure to airborne LAB and inhalable dust were measured at different 
places in the three different work areas. In total, 13 microbiological samples and 8 dust samples 
were collected. Airborne LABs were collected with an impactor (MAS-100 Eco, Merck, 
Darmstadt, Germany) at a flow rate of 100 l /min, onto Man Rogosa Shape agar plates (Oxoid, 
Basel Switzerland). Duplicate samples were taken at each sampling site. One of the duplicate 
plates was incubated at 30°C in an anaerobic atmosphere and the other plate in an aerobic 
atmosphere. All plates were checked daily for colony counts for 5 days. Results are expressed 
in Colony Forming Units (CFU) per cubic meter of air.  
Inhalable dust was sampled on glass fiber filters at a flow rate of 2.0 l/min using pocket pumps 
(MSA Escort Elf, Mine Safety Appliance Company, Pittsburgh, USA or SKC pocket pump 
210-1002, SKC Inc., USA) and IOM heads (SKC Inc.). Samplings were performed 
continuously for 1-4 hours at stationary points. The filters were pre and post-weighed on an 
analytical balance (Mettler Toledo AT201, Greifensee, Switzerland, 0.001 mg sensitivity) 
Immunological tests 
Every blood sample was tested for antibodies to the different LAB used and to 
carbohydrate, and then compared to a control group with an urban life-style.  
The antigens were produced from the LAB strains and carbohydrate. Thus, seven different 
antigens were produced and the blood samples were tested using two different immunological 
methods (ELISA IgG and electrosyneresis on cellulose acetate) for antibodies against the 6 
somatic antigens derived from each bacterium and one crude extract made with carbohydrate. 
Antigen extraction: Crude carbohydrate was  covered with liquid of Coca (4g sodium chloride, 
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2.75g bicarbonate of sodium, 4g liquid phenol and completed to 1 l with sterilized distilled 
water) and put to soak for 7 days at room temperature under shaking at 300 rev/min. Then, a 
series of filtration steps were carried out using different filter papers, the last one having a 
porosity of  0.45µm (Millipore Corp., Bedford, MA, USA). The filtrate was lyophilized 
(Labconco, Kansas City, MB, USA) and the antigen was reconstituted with sterile distilled 
water at a concentration of 100mg/ml.  Six somatic antigens were derived from six LAB 
strains. The antigens were produced as previously described 10. Briefly, bacteria strains were 
cultured on Mueller Hinton medium (Bio-Rad, Marnes la Coquette, France) for 1 week, 
sonicated, extracted overnight in NH4 CO3 at 4°C, centrifuged at 13,000 RPM, lyophilised and 
dosed for standardization at 100mg/ml of protein.  
Serology techniques: Workers’ sera were tested for each of the seven antigens using 
two parallel methods. Serum precipitins were analysed by electrosyneresis on cellulose 
acetate and ELISA with peroxydase-conjugated anti-human IgG. The results were interpreted 
separately by 2 persons; no differences were noted between their two interpretations. 
Serological techniques were previously described 11.  
Electrosyneresis: It was performed with an electrosyneresis apparatus (Sebia®, Issy les 
Moulineaux, France). After 10 minutes in a bath of buffered tris-glycine solution (Sebia®, Issy 
les Moulineaux, France), cellulose acetate sheets (Sartorius®, Goettingen, Germany) were 
dried and placed in the electrophoresis vat filled with buffered tris-glycin solution (pH=8.8). 
Fifteen microliters of each serum were placed on 3 spots on the anode side and a 15µL line of 
antigen was placed on the cathode side. A 110V current was applied for 2 hours and 15 
minutes. After washing, the cellulose acetate sheets were stained with Coomassie Brilliant 
Blue.  
ELISA: The wells of flat-bottom microtiter plates (Immulon, Prolabo®, Fontenay Sous 
Bois, France) were coated with 200µl of 10µg/ml antigen solution in 50mmol/l K2HPO4 
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buffer, pH 8.5 at 4°C for 72 hours. Excess binding sites were blocked at 37°C for 1 hour with 
250µl of 50mmol/l NaH2PO4, containing 0.5% bovine serum albumin and 60g/l of sorbitol. 
One hundred-microliter serum samples, diluted 1:50, were added to the wells in duplicate. 
The plates were incubated at 37°C for 1 hour and shaken constantly. Plates were washed four 
times with washing buffer (100mmol/l Tris-HCl, pH 7.5 containing 0.25% Tween). Next, 
100µl of peroxidase conjugated goat anti-human IgG diluted to 1:4,000 (Sigma®, Saint Louis, 
Missouri) were added to all wells and the plates were incubated at 37°C for 1h and shaken 
constantly. The washing procedure was repeated and 100µl of 3.3’.5.5’- 
Tetramethylbenzidine (TMB) solution (TMB One-Step Substrate System, Dako®, Carpinteria, 
California) was added to the wells at room temperature for 10 minutes. To stop the TMB 
reaction, 100µL of an acid solution (a mixture of 1N HCL and 3N H2SO4) were added. Wells 
were read spectrophotometrically at 450nm (Titertek Multiskan®, Helsinki, Finland) and the 
results were expressed in optical density (od). 
  
RESULTS 
Airborne LAB and inhalable dust  
Results for airborne LAB and inhalable dust are detailed in Table I. The level of 
airborne cultivable LAB was very low in the laboratory. In the pilot plant, low levels of aerobic 
LAB were measured, but intermediate levels of anaerobic strains. At the time of the study, the 
preblend conditioning room was the most exposed workplace with airborne bacteria level 
above Switzerland’s occupational health recommendations (10’000 CFU/m3; SUVA, 2009). 
We observed a positive correlation between inhalable dust levels and the level of airborne 
aerobic and anaerobic LAB (Spearmann ρ = 0.829). 
 
Health assessment and heath symptoms 
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 Data on participants are given in Table II. None of the participants had any relevant 
dust exposure before starting employment at the manufacturing site. The average career length 
of all the individuals in this industrial environment was 17 years (min = 1 year; max = 42 
years).  
In general, all participants were in good health conditions. There was no evidence of 
any relationship between medical consultation or regular prescribed medication and exposure 
to LAB and/or other powder. None of the individuals presented allergies related to exposure at 
work. There were no pathological results for the heart and lung auscultations. However, 46% 
(23/50) of participants reported past health symptoms or health incidents in relation to their 
exposure to preblend and milk powder. Some reported only one incident over the whole 
observation period (2002-2009); others were still reporting health problems. Most of the 
complaints concerned the eyes, nose or throat (31/36). Seventy-five percent of reported health 
complaints occurred rarely, 19% often, and 6% regularly. Tables III and IV show the 
prevalence of existing declared symptoms, as a function of their present workplace (Table III) 
and self declared exposure (Table IV). While most of the symptoms occur among subjects 
working in the factory, the difference is not significant, except for skin symptoms. On the other 
hand, it is noticeable that declared symptoms occur only in the group of subjects reporting a 
frequency of exposure greater than 10% and who did not consistently use the personal 
protective devices when exposed. This difference in symptoms prevalence between exposure 
groups is statistically significant (p=0.002 Fisher’s exact test). Spirometric test values, on the 
other hand, are on average above the expected values and do not differ according to the 
exposure. 
Immunological status  
Strains of Lactobacillus induce the most specific immune response. In total, 52% 
(23/44) of the blood samples showed a positive result (defined as a result up to two standard 
10 
 
deviations from the control group’s results) for one of the three lactobacilli (either in 
electrosyneresis or ELISA), most of them for L. paracasei and L. rhamnosus. None of the 
workers showed a reaction to carbohydrate. 
We found no statistically significant association between positive blood results (positive 
immunological reaction to one of the three Lactobacillus, either in ES or ELISA) and the work 
area, self-reported exposure or self-reported symptoms (Chi-square test respectively: 0.076, p = 
0.783; 0.613, p= 0.736; 0.08, p = 0.78). 
Nevertheless the results indicate a specific immune reaction to the LABs L. paracasei 
and L. rhamnosus in exposed workers compared with an unexposed control group (Wilcoxon 
test, repectively: Z= -4.7, p<0.001; Z=-4.8, p<0.001). On average, workers exposed to LABs 
have an immune response to L. paracasei 3 times higher than that of the control group (Mean 
+/- SE = 684 +/- 27 vs 203 +/- 18; N= 44/31), and workers exposed to LABs have an immune 
response to L. rhamnosus 2 times higher than that of the control group (Mean +/- SE = 420 +/- 
23 vs 193 +/- 18; N= 44/31). 
 
DISCUSSION 
The present study provides evidence that workers exposed to preblend (LAB mixed 
with carbohydrate) and milk powder, whether by inhalation or dermal contact and without 
adequate use of the PPE, are at an increased risk of developing irritating eye and nasal 
symptoms. We cannot compare the frequency of these health effects with a non exposed 
population, but the fact that about the half of the study population reported the occurrence of at 
least one eye or nose/throat symptom related to preblend handling during the period 2002-2009 
means that symptoms are in relationship with that specific work and are not due to other 
environmental sources. As workers were exposed to LAB, carbohydrate and milk powder, we 
cannot know which of those three components is responsible for the observed health symptoms. 
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The fact that, workers from areas with higher levels of airborne LAB reported the most health 
symptoms and the fact that the immune responses of workers to LAB was higher than 
compared to the immune responses of a control population could suggest that LAB could have 
a role in the apparition of irritating symptoms. However, exposure to airborne milk powder is 
also known to induce nasal symptoms. Indeed, another study 12, in dairy food industries in 
Thailand had reported that workers exposed to milk powder and/or vitamin by inhalation, had 
an increased risk of nasal symptoms. This study reported also other health symptom such as 
wheezing, breathlessness and decrease of lung function tests.  The difference in the gravity of 
the health symptoms between the Thai study and our study could be due to the fact that Thai 
workers do not used PPE. Comparison between health symptoms of workers exposed only to 
milk powder and workers exposed only to preblend would be necessary to clarify the specific 
health effect of each component. 
Even if the exposed group of workers show an increased immunological reaction 
against some LAB strains compared to a control group, our data do not allow us to show a 
relationship between immunological results, reported symptoms and/or medical history. But the 
absence of a relationship between immunological reaction and symptoms could also be due to a 
lack of statistical power because of the low number of individuals included in the analysis. It 
cannot be excluded that the duration of the exposition (17 years on average) and microbial 
airborne concentrations were insufficient to induce any symptoms, but we cannot exclude the 
hypothesis that under certain environmental circumstances, symptoms result from an increase 
in precipitins: for instance in the factory where preblends are conditioned, with up to 2.6x106 
CFU/m3 aerobic bacteria. However, our results suggest the self-reported symptoms seem to be 
more related to an irritating mechanism than to an allergic one. Currently, testing for specific 
antibodies against LABs seems unhelpful for the identification of individuals with health 
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problems or facing high exposure levels. This could provide an area for further research and 
studies. 
Looking at the reported symptoms in relation to the total number of years worked in the 
company, we observed – even if there is no significant statistical association – that individuals 
having worked less than 8 years at the company, reported more symptoms than those who had 
worked there for more than 8 years. This could be related to the “healthy worker effect” (a 
selection effect by which ill workers are less likely to be employed) frequently observed in 
work situations, particularly in cases involving irritating and allergic problems 13 . 
Among workers reporting at least one symptom related to contact with preblends during 
the last 12 months, we observed no complaints from staff in the laboratory and twice as many 
complaints in the staff of preblend conditioning room than in the pilot plant. These results are 
in accord with the airborne bacteria exposure measurements which showed that workers in the 
preblend conditioning room were exposed to up to five times more LAB than workers in the 
pilot plant, and that workers in the laboratory were exposed to very low amounts of airborne 
LAB since they handled very small quantities of powder. 
The risk of developing irritating symptoms is rare (less than once a month), and the data 
do not allow the evaluation of whether the occurrence of symptoms is due to specific work 
processes (e.g. during extremely high exposure to the microbial substances) or whether they are 
due to other circumstances. We did not find any evidence for increased numbers of sick days 
related to exposure to preblends in the workers’ medical histories. However, these workers 
should be regularly monitored for skin and mucous membrane problems and should receive 
sufficient training in the use of PPE in order to prevent health deteriorations. 
The documented health problems in this survey were only reported retrospectively by 
the individuals themselves. It may be advisable to examine exposed individuals in a future 
prospective survey, evaluating and diagnosing health problems when they occur to get more 
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information about the relationship between health problems, exposure and work processes. To 
conclude, the present study indicates that workers exposed to preblend and/or milk powders by 
inhalation or dermal contact are at an increased risk of developing irritating symptoms of the 
eyes, throat, and nose. Moreover, the use of PPE at times of significant exposure is sufficient to 
protect against the risk of developing such irritating symptoms.  
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Table I: Mean (range) of inhalable dust and airborne bacteria at different work areas of a food processing plant. 
 
Work area  Mean of dust [mg/m3] 
Mean of 
aerobic 
LAB 
(CFU/m3 ) 
Mean of anaerobic 
LAB 
(CFU/m3) 
Laboratory: during weighing of LAB 
0.772 
150 
N = 2 
(100-200) 
300 
N = 2 
(300) 
Laboratory: during handling of LAB  
< 0.015 
350 
N = 4 
(300-400) 
200 
N = 4 
(0-300) 
Pilot plant: command airlock 
- 
60 
N= 2 
(40-80) 
2'200 
N=2 
(1020-3380) 
Pilot plant: inside the room where the dry LAB 
 is distributed into big bags 
0.791 
N=2 
(0.176-1.407) 
200 
N=2 
(200) 
4’200 
N=2 
(4100-4300) 
Pilot plant: outside the room where the dry LAB 
 is distributed into big bags 0.021 
55 
N=2 
(50-60) 
1’110 
N=2 
(1000-1220) 
Factory: preblend conditioning room,  
during bag filling  4.714 
N=2 
(3.682-5.746) 
21’100 
N=2 
(20’600-21160) 
27’200 
N=2 
(26’700-27'700) 
Factory: preblend conditioning room, 
during preblends mixing > 2'628'000 > 2'628'000 
Factory: airlock where big bags are loaded before being 
sent to others plants. 1.802 
11’950 
N=4 
(8500-16’600) 
16’525 
N=4 
(10’600-22’700) 
Workers’ changing room: before entering in preblend 
conditioning room - 
6’840 
N=2 
(6’480-7’200)) 
8’525 
N=2 
(7’750-9’300) 
Goods depot 
- 
420 
N=2 
(400-440) 
230 
N=2 
(200-260) 
Cafeteria (control) 
- 
150 
N=2 
(140-160) 
30 
N=2 
(30) 
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Table II: Data on participants 
 Laboratory 
N=6 
Pilot Plant 
N=15 
Factory 
N=29 
Gender  n (%)    
 Male  1 (16.7%) 15 (100%) 27 (93.1%) 
 Female 5 (83.3%) - (-) 2 (6.9%) 
Age mean (sd) 38.0 (8.5) 46.7 (8.8) 44.0 (11.3) 
Smoking habits n (%)    
 Non smoker 5 (83.3%) 7 (46.7%) 15 (51.7%) 
 Former smoker 1 (16.7%) 6 (40.0%) 7 (24.1%) 
 Smoker - (-) 2 (13.3%) 7 (24.1%) 
Self declared exposure n (%)    
 <10% exposure 5 (83.3%) 4 (28.6%) 5 (20.0%) 
 ≥10% protection mask - 2 (14.3%) 3 (12.0%) 
 ≥10% no mask 1 (16.7%) 8 (57.1%) 17 (68.0%) 
 Missing information - 1 4 
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Table III: Prevalence of existing declared symptoms, as a function of their present workplace  
 Laboratory 
N=6 
Pilot Plant 
N=15 
Factory 
N=29 
P  
Respiratory parameters      mean (sd)     
 FEV1 (% predicted) 101.0 (4.1) 102.7 (12.1) 103.2 (14.4) >0.5 
 FVC (% predicted) 108.7 (5.9) 104.1 (9.3) 105.9 (16.4) >0.5 
Present work-related symptoms n (%)     
 Nose/Throat 0(-%) 2 (13.3%) 4 (13.8%) >0.5 
 Skin 0(-%) 0(-%) 8 (27.8%) 0.03 
 Eyes 0(-%) 1 (6.7%) 4 (13.8%) >0.5 
 Any symptom 0(-%) 3 (20.0%) 12 (41.4%) 0.09 
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Table IV: Prevalence of existing declared symptoms and self declared exposure. 
Self declared exposure <10% 
exposure 
N=14 
≥10% with 
protection mask 
N=5 
≥10% no mask 
N=26 
P  
Respiratory parameters      mean (sd)     
 FEV1 (% predicted) 106.6 (14.3) 107.6 (4.8) 101.6 (12.5) >0.5 
 FVC (% predicted) 108.4 (16.3) 102.6 (5.4) 106.6 (13.0) >0.5 
Present work-related symptoms n (%)     
 Nose/Throat 0 (-%) 0 (-%) 6 (23.1%) 0.10 
 Skin 0 (-%) 0 (-%) 7 (26.9%) 0.08 
 Eyes 0 (-%) 0 (-%) 3 (11.5%) >0.5 
 Any symptom 0 (-%) 0 (-%) 12 (46.2%) 0.002 
 
 
 
 
 
